Seres Therapeutics
MCRB
MCRB
137 hedge funds and large institutions have $538M invested in Seres Therapeutics in 2023 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 23 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.24% more ownership
Funds ownership: 4.15% → 4.39% (+0.24%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less capital invested
Capital invested by funds: $594M → $538M (-$55.9M)
Holders
137
Holding in Top 10
2
Calls
$12.8M
Puts
$4.23M
Top Buyers
| 1 | +$23M | |
| 2 | +$9.8M | |
| 3 | +$6.47M | |
| 4 |
BlackRock
New York
|
+$5.9M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$5.77M |
Top Sellers
| 1 | -$25M | |
| 2 | -$18.6M | |
| 3 | -$4.36M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.38M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.34M |